CYP1B1 is a critical metabolic enzyme for melatonin metabolism, and its role in cancer has been emphasised; this suggests that dysregulated expression of CYP1B1 is associated with the tumour’s clinical stage, grade, survival, and immune microenvironment [101]. This evidence concerns the gene CYP1B1 and cancer.